Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share

Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results

November 14, 2014 8:03 AM EST

CORAL GABLES, Fla., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Catalyst Pharmaceuticals) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today reported financial results for the third quarter and nine months ended September 30, 2014.

"With the announcement of the positive results from our pivotal Phase 3 trial of Firdapse in LEMS, the third quarter was truly transformative for Catalyst as it puts us on a pathway to initiate our NDA filing next year," said Patrick J. McEnany, Chairman and Chief Executive... More